Absence of Growth–Hormone Receptor in Hepatocellular Carcinoma and Cirrhotic Liver

Publisher Website
Google Scholar
Abstract
Hepatocellular carcinoma is a hormone–sensitive tumor. It has been reported that thyroxine and prolactin significantly stimulated hepatoma growth, whereas growth hormone failed to do so. To learn whether the growth hormone receptor is present in human hepatocellular carcinoma, we used radioreceptor assays in samples of human hepatocellular carcinoma. The liver tissues adjacent to hepatocellular carcinoma (mostly cirrhotic) and control liver tissues (taken during various surgical procedures) were also studied. The study results showed that the affinity constant and capacity of high–affinity growth hormone receptor in normal liver tissues were 6.6 ± 2.0 × 1010 mol/L-1 (mean ± SE, n = 7) and 20.7 ± 11.5 fmol/mg protein, respectively. The affinity constant and capacity of low–affinity growth hormone receptor in normal liver tissues were 8.9 ± 3.3 × 109 mol/L-1 and 64.7 ± 32.1 fmol/mg protein, respectively. The absence of growth hormone receptor in human hepatocellular carcinoma and cirrhotic liver samples may explain the absence of growth hormone in the stimulation of hepatoma growth and the decrease of somatomedin levels in cirrhosis. (HEPATOLOGY 1990; 11: 123-126)